[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"carcinoma-papillary\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:carcinoma-papillary":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100595524","hybrid-endoscopic-hemithyroidectomy-and-targeted-ablation-for-bilateral-papillary-thyroid-carcinoma-100595524",false,"NCT07033572","Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma","Inclusion Criteria:\n\n* Age 18-65 years.\n* Dominant-side PTC ≤1.5 cm suitable for endoscopic resection.\n* Contralateral nodule ≤7 mm located ≥2 mm from posterior capsule.\n* No radiologic lymph-node metastasis on contralateral side.\n* Written informed consent.\n\nExclusion Criteria:\n\n* Extrathyroidal extension, gross nodal or distant metastasis.\n* Prior neck surgery, prior RFA\u002Fethanol injection, or neck irradiation.\n* Pregnancy or lactation.\n* Serious comorbidities precluding anesthesia or follow-up.","ALL","18 Years","65 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study evaluates a thyroid-function-preserving alternative to routine total thyroidectomy for bilateral papillary thyroid carcinoma (PTC). Eligible adults undergo remote-access gas-less axillo-breast endoscopic hemithyroidectomy with level VI dissection on the dominant side, followed by ultrasound-guided radiofrequency ablation (RFA) of a ≤7 mm contralateral focus during the same anesthesia. Outcomes include structural-recurrence-free survival, endocrine-function preservation, safety, and quality of life over 24 months.",[26,27],"Thyroid Neoplasms","Carcinoma, Papillary",[29,30,31,32],"Hybrid endoscopic thyroidectomy","Radiofrequency ablation","Thyroid function preservation","Bilateral Thyroid Carcinoma","RECRUITING","2025-07-01",{"date":36,"type":37},"2025-07-03","ACTUAL",{"date":39,"type":37},"2018-06-01",{"date":41,"type":20},"2028-06-30",{"name":43,"class":44},"Fujian Medical University","OTHER"]